Skip to main content
. Author manuscript; available in PMC: 2012 Mar 1.
Published in final edited form as: Transfusion. 2011 Mar 1;51(3):643–653. doi: 10.1111/j.1537-2995.2011.03063.x

Table 1.

Methods used by participating laboratories for detection of XMRV nucleic acids in whole blood samples

Lab Extraction
method
Blood
Volume
(µl)
Input
DNA
(ng)
Assay
#
Target Assay
type
Quant/
nested
Primer
Reference
CDC QIAamp
mini blood
400 1000 1 gag PCR
southern
Nested 9

2 pol PCR
southern
Nested 9

FDA (H)a QIAamp
mini blood
200 500–1000 gag PCR Nested 2

FDA (Lo) Qiagen
DNeasy
blood
200 30–50 1 gag PCR Nested 4

30–50 2 gag PCR Nested 4

GPb Magnetic-based
target
capture
50 N/A Duplex Proprietaryc TMAc N/A Unpublished

NCI Promega
Wizard
Genomic
DNA
500 4000 5’ UTR
of gag
PCR
SCAd
Quant Unpublishedd

WPI QIAamp
DNA mini
blood
250 100 5’ UTR
of gag
qPCR Quant 24
a

H=Hewlett

b

GP=Gen-Probe Inc

c

Gen-Probe employs a duplex transcription-mediated amplification (TMA) assay based on multiple proprietary probes

d

SCA=single-copy assay.

Forward primer: 5-TGTATCAGTTAACCTACCCGAGT-3’; Reverse primer: 5-AGACGGGGGCGGGAAG-3’; XMRV probe 5’fam-TGGAGTGGCTTTGTTGGGGGACGA- tamra3’